News and Information

Press Release

SEATTLE - Receptor Life Sciences today announced the appointment of Orrin Devinsky, M.D., as the company’s Chief Medical Officer.

Press Release

SEATTLE – Receptor Holdings, Inc. and its wholly-owned subsidiary, Receptor Life Sciences, a biopharmaceutical company developing cannabinoid medicines featuring distinct pharmaceutical drug delivery technologies, today announced that it raised $29 million in a combined convertible debt and Series A round of financing.


Receptor Life Sciences, Inc. today announced that it has entered into a collaboration and license agreement with MannKind Corporation.